Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-369.09%EBITDA Margin
VS
Market
Sector
Industry
History
$ 1.65Close
$ 0.39 - $ 1.81 52-Week Range
Ticker Information
Ticker
LCTXCompany Name
LINEAGE CELL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTLINEAGE CELL THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LCTX - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -40.28M | -369.09% | $ 10.91M |
| 3/31/2025 | $ -15.61M | -163.31% | $ 9.56M |
| 12/31/2024 | $ -18M | -189.49% | $ 9.5M |
| 9/30/2024 | $ -19.48M | -223.4% | $ 8.72M |
| 6/30/2024 | $ -23.52M | -380.2% | $ 6.19M |
| 3/31/2024 | $ -22.96M | -286.89% | $ 8M |
| 12/31/2023 | $ -22.6M | -252.62% | $ 8.95M |
| 9/30/2023 | $ -23.74M | -270.67% | $ 8.77M |
| 6/30/2023 | $ -22.52M | -214% | $ 10.52M |
| 3/31/2023 | $ -24.1M | -203.34% | $ 11.85M |
Key Performance Insights, Last 5 Years
- LINEAGE CELL THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -880.75%.
- Over the past 5 years, LINEAGE CELL THERAPEUTICS INC's average EBITDA % has been -434.84%.
- The median EBITDA % for LINEAGE CELL THERAPEUTICS INC during this period was -352.51%
- LINEAGE CELL THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at -163.31%.
- The lowest EBITDA % recorded by LINEAGE CELL THERAPEUTICS INC in the same timeframe -1083.08%
LINEAGE CELL THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for LINEAGE CELL THERAPEUTICS INC is calculated as follows: EBITDA [ $ -23.89M ] / Revenues [ $ 2.71M ]
(=) EBITDA % [ -880.75% ] LCTX - EBITDA Margin, Last 5 years
-1083.08%
Minimum
Dec 31, 2020
-163.31%
Maximum
Mar 31, 2025
-434.84%
Average
-352.51%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |